The adenoma hunt in colorectal cancer screening: Defining the target

Journal of Pathology

Volumn 226, Issue 1, 2012, Pages 1-6

  Sillars Hardebol, Anke H ^a   Carvalho, Beatriz ^a   Van Engeland, Manon ^b   Fijneman, Remond Ja ^a   Meijer, Gerrit A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

adenoma; colorectal cancer; screening intermediate endpoint; tumour biology

Indexed keywords

ACSL1 PROTEIN; ADH1A PROTEIN; ATM PROTEIN; ATP6V1 PROTEIN; AURORA A KINASE; CCT6A PROTEIN; COXC PROTEIN; CSK2 PROTEIN; CYCLIN B1; DEK PROTEIN; ENO2 PROTEIN; GPI PROTEIN; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE ISOENZYME 5; MDH1 PROTEIN; NME1 PROTEIN; OSTEONECTIN; PA2G4 PROTEIN; PGK2 PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PKM2 PROTEIN; PLATELET DERIVED GROWTH FACTOR B; PROTEIN; PYRUVIC ACID; RAN PROTEIN; SDHB PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; TNFRSF12A PROTEIN; TOP2A PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN;

ANGIOGENESIS; CANCER GROWTH; CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER SURGERY; CARCINOGENESIS; CELL DIFFERENTIATION; CELL INVASION; CELL PROLIFERATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOMAL INSTABILITY; CHROMOSOME 20Q; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; COPY NUMBER VARIATION; DIAGNOSTIC ACCURACY; DNA METHYLATION; FATTY ACID METABOLISM; FATTY ACID OXIDATION; GENE EXPRESSION; GENETIC RISK; GLUCONEOGENESIS; GLYCOLYSIS; HUMAN; MALIGNANT TRANSFORMATION; MICROSATELLITE INSTABILITY; PHENOTYPE; POLYPECTOMY; PRIORITY JOURNAL; PROBABILITY; REVIEW; RISK ASSESSMENT; SIGNAL TRANSDUCTION; STROMA; TUMOR VOLUME;

ADENOMA; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; HUMANS; MASS SCREENING; PRECANCEROUS CONDITIONS;

EID: 82755194911     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.3012     Document Type: Review

References (40)

1. Jemal A, Siegel R, Ward E, et al., Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
2. Levin B, Lieberman DA, McFarland B, et al., Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008; 134: 1570-1595. (Pubitemid 351615355)
3. Hoff G, Dominitz JA,. Contrasting US and European approaches to colorectal cancer screening: which is best? Gut 2010; 59: 407-414.
4. Paspatis GA, Papanikolaou N, Zois E, et al., Prevalence of polyps and diverticulosis of the large bowel in the Cretan population. An autopsy study. Int J Colorectal Dis 2001; 16: 257-261. (Pubitemid 32700703)
5. Shinya H, Wolff WI,. Morphology, anatomic distribution and cancer potential of colonic polyps. Ann Surg 1979; 190: 679-683.
6. Muto T, Bussey HJ, Morson BC,. The evolution of cancer of the colon and rectum. Cancer 1975; 36: 2251-2270.
7. Fearon ER, Vogelstein B,. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-767.
8. Robertson DJ, Greenberg ER, Beach M, et al., Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology 2005; 129: 34-41. (Pubitemid 41002040)
9. Vasen HF, Abdirahman M, Brohet R, et al., One- to two-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome. Gastroenterology 2010; 138: 2300-2306.
10. Hanahan D, Weinberg RA,. The hallmarks of cancer. Cell 2000; 100: 57-70. (Pubitemid 30046295)
11. Deberardinis RJ, Sayed N, Ditsworth D, et al., Brick by brick: metabolism and tumor cell growth. Curr Opin Genet Dev 2008; 18: 54-61. (Pubitemid 351694453)
12. Bell DW,. Our changing view of the genomic landscape of cancer. J Pathol 2010; 220: 231-243.
13. Grady WM, Carethers JM,. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 2008; 135: 1079-1099.
14. Deng S, Calin GA, Croce CM, et al., Mechanisms of microRNA deregulation in human cancer. Cell Cycle 2008; 7: 2643-2646.
15. Brosens RP, Haan JC, Carvalho B, et al., Candidate driver genes in focal chromosomal aberrations of stage II colon cancer. J Pathol 2010; 221: 411-424.
16. Fodde R, Tomlinson I,. Nuclear β-catenin expression and Wnt signalling: in defence of the dogma. J Pathol 2010; 221: 239-241.
17. Kim JC, Kim SY, Roh SA, et al., Gene expression profiling: canonical molecular changes and clinicopathological features in sporadic colorectal cancers. World J Gastroenterol 2008; 14: 6662-6672.
18. Carvalho B, Postma C, Mongera S, et al., Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression. Gut 2009; 58: 79-89.
19. Semenza GL,. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003; 3: 721-732. (Pubitemid 37328811)
20. Bartek J, Bartkova J, Lukas J,. DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene 2007; 26: 7773-7779. (Pubitemid 350242463)
21. Bartkova J, Rezaei N, Liontos M, et al., Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006; 444: 633-637. (Pubitemid 44864442)
22. Kuilman T, Peeper DS,. Senescence-messaging secretome: SMS-ing cellular stress. Nat Rev Cancer 2009; 9: 81-94.
23. Sillars-Hardebol AH, Carvalho B, de Wit M, et al., Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progression. Tumour Biol 2010; 31: 89-96.
24. Hermsen M, Postma C, Baak J, et al., Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability. Gastroenterology 2002; 123: 1109-1119.
25. Dvorak HF,. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315: 1650-1659. (Pubitemid 17052899)
26. Samuels Y, Ericson K,. Oncogenic PI3K and its role in cancer. Curr Opin Oncol 2006; 18: 77-82. (Pubitemid 43740454)
27. Winawer SJ, Flehinger BJ, Schottenfeld D, et al., Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst 1993; 85: 1311-1318. (Pubitemid 23249723)
28. Mandel JS, Church TR, Bond JH, et al., The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343: 1603-1607. (Pubitemid 32162983)
29. Lieberman DA,. Clinical practice. Screening for colorectal cancer. N Engl J Med 2009; 361: 1179-1187.
30. Ramsoekh D, van Leerdam ME, van Ballegooijen M, et al., Population screening for colorectal cancer: faeces, endoscopes or X-rays? Cell Oncol 2007; 29: 185-194. (Pubitemid 46855700)
31. Brenner H, Hoffmeister M, Arndt V, et al., Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J Natl Cancer Inst 2010; 102: 89-95.
32. Baxter NN, Goldwasser MA, Paszat LF, et al., Association of colonoscopy and death from colorectal cancer. Ann Intern Med 2009; 150: 1-8.
33. Allison JE,. The best screening test for colorectal cancer is the one that gets done well. Gastrointest Endosc 2010; 71: 342-345.
34. Health Council of The Netherlands. A national colorectal cancer screening programme. The Hague: Health Council of the Netherlands: 2009; Publication No. 2009/13E.
35. Allison JE, Sakoda LC, Levin TR, et al., Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 2007; 99: 1462-1470.
36. Ahlquist DA,. Molecular detection of colorectal neoplasia. Gastroenterology 2010; 138: 2127-2139.
37. Bosch LJ, Carvalho B, Fijneman RJ, et al., Molecular tests for colorectal cancer screening. Clin Colorectal Cancer 2011; 10: 8-23.
38. Melotte V, Lentjes MH, van den Bosch SM, et al., N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer. J Natl Cancer Inst 2009; 101: 916-927.
39. Jimenez CR, Knol JC, Meijer GA, et al., Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers. J Proteom 2010; 73: 1873-1895.
40. Bass AJ, Lawrence MS, Brace LE, et al., Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion. Nat Genet 2011; 43: 964-968.